Bio-Rad Laboratories Debt to Equity Ratio 2010-2022 | BIO.B

Current and historical debt to equity ratio values for Bio-Rad Laboratories (BIO.B) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bio-Rad Laboratories debt/equity for the three months ending March 31, 2022 was 0.12.
Bio-Rad Laboratories Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-03-31 $4.19B $10.18B 0.41
2021-12-31 $4.11B $13.67B 0.30
2021-09-30 $4.62B $15.33B 0.30
2021-06-30 $3.52B $11.60B 0.30
2021-03-31 $3.32B $10.61B 0.31
2020-12-31 $3.09B $9.88B 0.31
2020-09-30 $3.20B $8.83B 0.36
2020-06-30 $2.74B $7.35B 0.37
2020-03-31 $2.39B $6.29B 0.38
2019-12-31 $2.25B $5.76B 0.39
2019-09-30 $2.05B $5.13B 0.40
2019-06-30 $2.16B $5.49B 0.39
2019-03-31 $2.00B $4.86B 0.41
2018-12-31 $1.59B $4.02B 0.40
2018-09-30 $1.82B $4.90B 0.37
2018-06-30 $1.75B $4.64B 0.38
2018-03-31 $1.73B $4.49B 0.39
2017-12-31 $1.34B $2.93B 0.46
2017-09-30 $1.34B $2.85B 0.47
2017-06-30 $1.33B $2.81B 0.47
2017-03-31 $1.25B $2.71B 0.46
2016-12-31 $1.27B $2.58B 0.49
2016-09-30 $1.32B $2.70B 0.49
2016-06-30 $1.26B $2.62B 0.48
2016-03-31 $1.21B $2.54B 0.48
2015-12-31 $1.22B $2.49B 0.49
2015-09-30 $1.24B $2.43B 0.51
2015-06-30 $1.17B $2.36B 0.49
2015-03-31 $1.13B $2.20B 0.51
2014-12-31 $1.16B $2.19B 0.53
2014-09-30 $1.21B $2.18B 0.56
2014-06-30 $1.22B $2.25B 0.54
2014-03-31 $1.21B $2.23B 0.54
2013-12-31 $1.20B $2.19B 0.55
2013-09-30 $1.16B $2.12B 0.54
2013-06-30 $1.41B $2.07B 0.68
2013-03-31 $1.43B $2.03B 0.70
2012-12-31 $1.43B $2.02B 0.71
2012-09-30 $1.37B $1.94B 0.71
2012-06-30 $1.32B $1.85B 0.71
2012-03-31 $1.35B $1.84B 0.73
2011-12-31 $1.35B $1.74B 0.78
2011-09-30 $1.28B $1.69B 0.75
2011-06-30 $1.32B $1.73B 0.76
2011-03-31 $1.30B $1.61B 0.80
2010-12-31 $1.52B $1.54B 0.99
2010-09-30 $1.25B $1.43B 0.88
2010-06-30 $1.22B $1.30B 0.94
2010-03-31 $1.25B $1.30B 0.96
2009-12-31 $1.26B $1.28B 0.98
2009-09-30 $1.25B $1.23B 1.02
2009-06-30 $1.22B $1.13B 1.08
2009-03-31 $0.90B $1.06B 0.85
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.907B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00